What’s the deal with “Black Panther: Wakanda Forever?” That’s the question that many people are asking right now. Towards the end of 2021, it was revealed that star Letitia Wright was actually injured on the set of the film and this caused the entire production to be halted with everyone expecting to reconvene in January. But then it was reported that Wright’s anti-vax status might make it difficult for the actress to return to the US to film. Then there’s the issue of the delayed November release date (more on that in a bit). All that to say, lots of questions surrounding what should be one of the biggest hits of 2022.
READ MORE: The 100 Most Anticipated Films Of 2022
Well, according to the BBC, we can now say that Letitia Wright is back on the set of “Black Panther 2,” with production proceeding as planned. The report includes a quote from reps for Wright, who said, “Filming resumed this month as planned and we’re on schedule.” So, apparently, the Marvel Studios film is still on schedule to release in November. This is after the film was initially delayed due to Wright’s injury, but also because of the tragic death of Chadwick Boseman.
But does that mean everything is on track for a November release? Well, that’s the interesting question that isn’t yet answered. You see, as of now, “Black Panther: Wakanda Forever” is supposed to hit theaters on November 11. That’s only one week after Warner Bros.’ “The Flash” is supposed to arrive. It would seemingly be stupid for the studios to release these films so close together, as they would likely cannibalize each other. With WB having no issues with production and a teaser already released, you have to assume the studio is more than ready with “The Flash.” And even though Wright is back on set with ‘Wakanda Forever,’ it’s unclear just how much filming is left on the sequel.
All that to say, one of the films is going to have to move its date. And if ‘Wakanda Forever’ moves, it’ll likely end up in 2023, as “Avatar 2” has Disney’s blessing in December. We’ll have to wait and see.